BRAF and cutaneous mastocytosis: Early onset, anatomic site, and lack of relation to UV damage in BRAF-mutated CM reflect the distinct pathogenic pathways of melanocyte malignization, which are different from those of wild-type melanoma [18] and can also define the roots of the found predictive significance of the associated nevus on the probability of harboring BRAF mutations in CM.